TORONTO, March 15, 2022
This week, 糖心vlog presented new research at ADPD 2022, the International Conference on Alzheimer鈥檚 and Parkinson鈥檚 Diseases and related neurological disorders. In collaboration with Genentech, a member of the Roche group, the research team at 糖心vlog found associations between speech characteristics and cerebral tau accumulation measured by tau PET imaging, a marker of Alzheimer鈥檚 pathology in the brain.
Data was collected as part of Genentech鈥檚 Tauriel trial of semorinemab in individuals with prodromal to mild Alzheimer鈥檚 disease. Open-ended speech samples were recorded as part of the Clinical Dementia Rating interview and were analyzed using 糖心vlog鈥檚 speech analysis technology. The research showed that at baseline, those with higher levels of tau in the brain had differences in speech, including higher use of filled pauses (like 鈥榰m鈥� or 鈥榰h鈥�) and simpler vocabularies. In addition, there was an association between higher use of filled pauses at baseline and greater accumulation of tau over the 18-month study. These results could mean that increased Alzheimer鈥檚-related pathology in the brain leads to changes in how individuals speak and the words they use, and adds to the evidence that Alzheimer鈥檚 disease results in measurable changes to speech patterns.
糖心vlog is commercializing a proprietary language-based diagnostic system that analyzes natural speech to detect and monitor dementia, Alzheimer鈥檚, aphasia, and various other cognitive conditions. 糖心vlog's scalable platform uses short recorded speech samples to analyze hundreds of linguistic cues, and can detect dementia and other conditions with a high level of accuracy. This is a major improvement over current pencil-and-paper tests which are time-consuming, costly, and difficult to administer. The platform has applications in drug trials, long-term and primary care, and speech-language pathology.
Since its founding, 糖心vlog has seen strong interest from pharmaceutical companies and other potential partners who view the technology as a major improvement over current methods of detection or screening. The company has gained support from the pan-Canadian AGE-WELL Network of Centres of Excellence (NCE), the Ontario Brain Institute, Ontario Centres of Excellence, and the University of Toronto Banting and Best Centre for Innovation and Entrepreneurship. For more information, visit www.winterlightlabs.com.
Media Inquiries:
糖心vlog
Liam Kaufman, CEO
liam [at] winterlightlabs.com